Professor Naveed Sattar
Disclosure details
Naveed Sattar has consulted for and/or received speaker honoraria from Abbott Laboratories, AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Janssen, Menarini-Ricerche, Novartis, Novo Nordisk, Pfizer, Roche Diagnostics, and Sanofi; and received grant support paid to his University from AstraZeneca, Boehringer Ingelheim, Novartis, and Roche Diagnostics.Professor of Cardiometabolic Medicine, University of Glasgow
Naveed Sattar, Professor of Cardiometabolic Medicine, is clinically active in cardiometabolic disease. He has epidemiology, mechanistic and trial expertise in diabetes, obesity and cardiovascular disease, having contributed to several lifestyle (e.g. DIRECT, STANDBY, UPBEAT, EUROFIT) and drug (e.g. REMOVAL, TRUST, AMPLITUDE-O, EMPEROR Heart failure) trials and has ongoing activity in several outcome trials, with an increasing focus on weight management. He is internationally recognised in cardiometabolic medicine and has a track record of collaboration in other disciplines where his outputs have helped shape specific areas of clinical practice. He has been on several national and international guideline committees, including: European Society of Cardiology (ESC) Task Force to develop 2023 Guidelines on diabetes and cardiovascular diseases; Joint British Societies 3 CVD prevention recommendations; SIGN obesity and CVD prevention guidelines (as Chair); and European CVD prevention guidelines. He has authored/co-authored more than 1,300 published papers and has received several national and international awards for his research, including the prestigious Camillo Golgi (2020) and Minkowski Prizes (2011), both from European Association for the Study of Diabetes (EASD), and the Banting Memorial (2022) and Rank Nutrition Lectures (2018), both from Diabetes UK. He is amongst the world’s most cited academics (top 1% of field) in Clinical Medicine, having featured on the Clarivate Analytics/Web of Science global Highly Cited Researcher list annually since 2014. He has been cited >135K times (Web of Science) and >220K (Google Scholar) and was #185 all-time cited in medicine in a recent listing World’s Best Medicine Scientists: H-Index Medicine Science Ranking 2023 (Research.com). He sits on a variety of advisory boards and programme committees, is on the BMC Medicine editorial board, is an Associate Editor for Diabetes Care, and past Associate Editor for Circulation and Diabetologia. He has presented at numerous national and international meetings and conferences. In late 2023 he was appointed as the UK Government’s new Obesity Mission Chair.
